Axon Enterprise, Inc $AXON Shares Bought by J.Safra Asset Management Corp

Posted by Brenda Bartman on Aug 17th, 2026

J.Safra Asset Management Corp lifted its position in Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 45.1% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 3,367 shares of the biotechnology company’s stock after buying an additional 1,047 shares during the period. J.Safra Asset Management Corp’s holdings in Axon Enterprise were worth $1,888,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of AXON. Edgewood Management LLC acquired a new position in Axon Enterprise during the fourth quarter worth about $846,516,000. Wellington Management Group LLP lifted its holdings in Axon Enterprise by 326.9% in the 4th quarter. Wellington Management Group LLP now owns 1,539,738 shares of the biotechnology company’s stock valued at $874,463,000 after acquiring an additional 1,179,038 shares during the last quarter. Norges Bank acquired a new stake in Axon Enterprise in the 4th quarter valued at about $515,764,000. Styrax Capital LP acquired a new stake in Axon Enterprise in the 1st quarter valued at about $84,938,000. Finally, Sands Capital Management LLC boosted its position in shares of Axon Enterprise by 11.6% during the 4th quarter. Sands Capital Management LLC now owns 1,609,436 shares of the biotechnology company’s stock valued at $914,047,000 after purchasing an additional 167,095 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Key Stories Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

Positive Sentiment: Axon reported quarterly earnings of $1.88 per share, exceeding the $1.84 consensus estimate, while revenue reached $904.4 million versus expectations of $876.4 million. Revenue increased 35.3% year over year, reinforcing the growth outlook for its public-safety technology, connected devices and software businesses. Axon Enterprise stock in focus after strong quarter
Positive Sentiment: A Motley Fool article highlighted Axon as a category leader that continues to deliver double-digit revenue growth despite trading below its prior high, supporting the case for long-term investors willing to hold the stock for a decade. Two stocks to buy and hold for the next decade
Positive Sentiment: Northland Securities raised its FY2027 EPS forecast to $6.49 from $5.53 and increased estimates for the first three quarters of 2027. The firm also lifted its Q3 2026 estimate to $1.01 from $0.85, signaling stronger anticipated earnings momentum beyond the current year.
Neutral Sentiment: Northland’s revisions were mixed: it reduced its FY2026 EPS forecast to $3.12 from $3.26 and lowered Q4 2026 expectations to $1.29 from $1.55, while raising several 2027 forecasts. This suggests near-term execution concerns but improved longer-term expectations.
Negative Sentiment: AXON’s valuation remains demanding, with a reported price-to-earnings ratio above 250 and a PEG ratio near 10. Strong growth is already reflected in the share price, leaving the stock vulnerable to profit-taking or disappointment if future results do not exceed elevated expectations.

Axon Enterprise Stock Performance

NASDAQ:AXON opened at $612.83 on Monday. The stock has a fifty day simple moving average of $526.06 and a 200 day simple moving average of $473.48. The firm has a market capitalization of $49.79 billion, a price-to-earnings ratio of 254.29, a price-to-earnings-growth ratio of 9.95 and a beta of 1.39. Axon Enterprise, Inc has a 1-year low of $339.01 and a 1-year high of $794.29. The company has a quick ratio of 1.80, a current ratio of 2.15 and a debt-to-equity ratio of 0.47.

Axon Enterprise (NASDAQ:AXON – Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.84 by $0.04. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%.The firm had revenue of $904.39 million for the quarter, compared to the consensus estimate of $876.42 million. During the same quarter in the previous year, the company earned $2.12 EPS. The business’s revenue for the quarter was up 35.3% compared to the same quarter last year. Sell-side analysts forecast that Axon Enterprise, Inc will post 2.04 earnings per share for the current year.

Insiders Place Their Bets

In other news, insider Isaiah Fields sold 2,000 shares of the business’s stock in a transaction that occurred on Friday, May 22nd. The shares were sold at an average price of $400.00, for a total transaction of $800,000.00. Following the sale, the insider owned 52,813 shares in the company, valued at $21,125,200. The trade was a 3.65% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Elizabeth Reid Coughlin sold 1,554 shares of the business’s stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $485.00, for a total transaction of $753,690.00. Following the sale, the insider owned 34,024 shares in the company, valued at $16,501,640. This represents a 4.37% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 68,989 shares of company stock valued at $36,016,932 over the last 90 days. 4.20% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

AXON has been the topic of several recent research reports. Zacks Research cut shares of Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 10th. Weiss Ratings reissued a “hold (c-)” rating on shares of Axon Enterprise in a research note on Wednesday, August 5th. Morgan Stanley raised their target price on shares of Axon Enterprise from $600.00 to $640.00 and gave the stock an “overweight” rating in a report on Thursday, August 6th. JPMorgan Chase & Co. lifted their price target on shares of Axon Enterprise from $750.00 to $755.00 and gave the stock an “overweight” rating in a research report on Thursday, May 7th. Finally, Needham & Company LLC reaffirmed a “buy” rating on shares of Axon Enterprise in a report on Thursday, August 6th. Thirteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $730.92.

Check Out Our Latest Research Report on AXON

About Axon Enterprise

(Free Report)

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.